T-cell Childhood Acute Lymphoblastic Leukemia (DBCOND0028599)

Identifiers

Synonyms

Childhood T Acute Lymphoblastic Leukemia

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT00101205	Oxaliplatin, Ifosfamide and Etoposide in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma	Etoposide Oxaliplatin	treatment	1	terminated
NCT00873093	Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma	Asparaginase Escherichia coli Aspartic acid Bortezomib Bortezomib D-mannitol Cyclophosphamide Cytarabine Doxorubicin Etoposide Filgrastim Hydrocortisone Leucovorin Methotrexate Pegaspargase Prednisone Vincristine	treatment	2	completed
NCT00382109	Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission	Cyclophosphamide Methotrexate Sirolimus Tacrolimus Thiotepa	treatment	3	completed
NCT01093586	Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies	Antilymphocyte immunoglobulin (horse) Antithymocyte immunoglobulin (rabbit) Busulfan Cyclophosphamide Cyclosporine Methylprednisolone Methylprednisolone hemisuccinate Mycophenolate mofetil	treatment	2	completed
NCT00898404	Response or Resistance to Chemotherapy in Young Patients With Acute Lymphoblastic Leukemia Treated With Methotrexate	No drug interventions	Not Available	Not Available	completed
NCT00016302	Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia	Asparaginase Escherichia coli Aspartic acid Cyclophosphamide Cytarabine Daunorubicin Dexamethasone Doxorubicin Leucovorin Mercaptopurine Methotrexate Nelarabine Pegaspargase Prednisone Sulfate ion Tioguanine Vincristine	treatment	Not Available	completed
NCT00061945	Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia	Acyclovir Alemtuzumab Allopurinol Asparaginase Escherichia coli Cyclophosphamide Cytarabine Daunorubicin Dexamethasone Filgrastim Imatinib Leucovorin Mercaptopurine Methotrexate Sulfamethoxazole Trimethoprim Vincristine	treatment	1 / 2	completed
NCT00002970	506U78 in Treating Patients With Refractory Hematologic Cancer	Cytarabine Hydrocortisone Methotrexate Nelarabine	treatment	2	completed
NCT01088763	Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia	Dexamethasone RG-4733	treatment	1	terminated
NCT00052520	Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation	Aldesleukin Therapeutic allogeneic lymphocytes	treatment	1 / 2	completed
NCT00049569	Combination Chemotherapy and Imatinib Mesylate in Treating Children With Relapsed Acute Lymphoblastic Leukemia	Asparaginase Escherichia coli Cyclophosphamide Cytarabine Doxorubicin Etoposide Filgrastim Hydrocortisone Imatinib Leucovorin Methotrexate Pegaspargase Prednisone Vincristine	treatment	Not Available	completed
NCT00557193	Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia	Asparaginase Escherichia coli Aspartic acid Beta-D-Glucose Calcium Cortisone Cyclophosphamide Cytarabine Daunorubicin Dexamethasone Etoposide Filgrastim Hydrocortisone Hydrocortisone acetate Lestaurtinib Leucovorin Levoleucovorin Mercaptopurine Methopterin Methotrexate Methylprednisolone Pegaspargase Prednisone Sulfate ion Vincristine	treatment	3	completed
NCT01403415	Temsirolimus, Dexamethasone, Mitoxantrone Hydrochloride, Vincristine Sulfate, and Pegaspargase in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma	Asparaginase Escherichia coli Dexamethasone Menthol Methopterin Methotrexate Mitoxantrone Pegaspargase Sirolimus Sulfate ion Temsirolimus Vincristine	treatment	1	completed
NCT02112916	Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma	Asparaginase Escherichia coli Beta-D-Glucose Bortezomib Bortezomib D-mannitol Calcium Cyclophosphamide Cytarabine Daunorubicin Dexamethasone Doxorubicin Ethanol Etoposide Hydrocortisone Hydrocortisone succinate Ifosfamide Leucovorin Levoleucovorin Mercaptopurine Methopterin Methotrexate Pegaspargase Sodium succinate Sulfate ion Tioguanine Vincristine	treatment	3	active_not_recruiting
NCT00437060	Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia	No drug interventions	Not Available	Not Available	completed